Qiang Qu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 8
-
- Genomics, phytochemicals, and oxidative stress 6
- Epigenetics and DNA Methylation 6
-
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Epilepsy research and treatment 7
- Partner nations
- ChinaUnited States
In The Last Decade
Qiang Qu
66 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 458
- Applied Microbiology and Biotechnology 33
- Molecular Medicine 65
- Molecular Biology 684
- Biological Psychiatry 16
Countries citing papers authored by Qiang Qu
This map shows the geographic impact of Qiang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Qu more than expected).
Fields of papers citing papers by Qiang Qu
This network shows the impact of papers produced by Qiang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Qu. The network helps show where Qiang Qu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiang Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 23 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 58 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 9 | |
| 15 | 2016 | 14 | |
| 16 | 2016 | 15 | |
| 17 | 2015 | 27 | |
| 18 | 2014 | 24 | |
| 19 | 2014 | 30 | |
| 20 | Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. | 2013 | 48 |
About Qiang Qu
Qiang Qu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers), Cancer-related molecular mechanisms research (7 papers), Epilepsy research and treatment (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Epigenetics and DNA Methylation (6 papers), MicroRNA in disease regulation (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Cancer Research (458 citations), Applied Microbiology and Biotechnology (33 citations) and Molecular Medicine (65 citations). Qiang Qu has collaborated with scholars based in China and United States. Frequent co-authors include Jian Qu, Hong‐Hao Zhou, Qiong Lu, Qiao‐Li Lv, Lei Hu, Shuhui Chen, Tingting Qi, Haihong Zhu, Bao Sun and Hong‐Hao Zhou. Their work appears in journals such as Blood, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.